The Pfizer Clinical Research Unit in New Haven is conducting a clinical trial of a study drug for obesity. This study will look at the effects of the study drug when given as a single injection beneath the skin (subcutaneous [SC] injection) in different areas of the body (abdomen, thigh, or upper arm).
Obesity is a chronic weight condition that increases the potential risk of other illnesses such as stroke and diabetes. By 2030, it is projected that over a billion people worldwide will be considered obese.
While the scientific and medical community defines obesity as a complex, multifactorial chronic disease requiring prevention and treatment efforts, there are still many misconceptions and stigma associated with this condition which can further impact patients’ quality of life and access to healthcare. Most people with obesity do not receive any treatment, and diet and lifestyle are often not effective at long-term weight management for many patients.
Learn how you can help support patients as a healthy volunteer.
Who may participate
Clinical trial participants are an essential part of discovering new or better ways to treat disease.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to receive an injection of the study drug beneath the skin
- Willing and able to come to our facility in New Haven, CT for the admission period and all overnights*
- Have a current BMI between 27 and 45
*participants may be eligible to receive a bonus for study travel, ask our staff for details
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Obesity
Age
18+ years
Sex
All sexes
Referral bonus
Up to $150
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 8 consecutive overnights. The morning after you check-in, you will receive a single injection of the study drug under the skin of your abdomen, thigh, or upper arm. You will then remain at the PCRU for observation for the next 7 nights. After the completion of the in-house stay, you will return to the PCRU for 5 more visits over the course of about 3 months, each lasting a few hours.
The full study schedule will be shared with you before and during your screening appointment. We ask you to check this schedule carefully to be sure that all dates work for you and to let staff know if you have any concerns ahead of time.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
This study requires you to stay at the PCRU for the entire duration listed unless you choose to withdraw. You can learn more about what to expect during your participation by browsing our FAQ section.
Required overnight stays
8 consecutive overnights
Long-term follow up
5 visits over ~3 months
How long is this study?
About 86 days
Compensation
Up to $6,100 upon completion of the study
We've updated the PCRU Loyalty Program!
We refreshed our Participant Loyalty Program with all-new unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.